Researchers reviewed 34 studies involving experimental cancer models to see how parasites and their components, such as proteins and peptides, affect cancer. The study looked at both ways these substances might interact with tumors in laboratory settings.
The findings show a complex relationship. Some parasite-derived molecules were linked to pro-tumor effects, which are associated with chronic inflammation, oxidative stress, and immune modulation. Other components showed anti-tumor effects by causing direct cell death, stopping the movement of cancer cells, and activating the immune system.
It is important to note that these results come from experimental models, not from human clinical trials. The specific outcome depends heavily on the type of parasite, the specific molecules involved, and how the host's body responds. While some components show potential as new ways to treat cancer, others may contribute to cancer growth. These findings are early and do not currently change standard medical practices.
